We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Oxford Gene Technology Launches Cytosuretm Products for the Cytogenetics Research Community
Product News

Oxford Gene Technology Launches Cytosuretm Products for the Cytogenetics Research Community

Oxford Gene Technology Launches Cytosuretm Products for the Cytogenetics Research Community
Product News

Oxford Gene Technology Launches Cytosuretm Products for the Cytogenetics Research Community


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Oxford Gene Technology Launches Cytosuretm Products for the Cytogenetics Research Community"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Oxford Gene Technology (OGT) announces the launch of two array CGH (aCGH) products designed for the cytogenetics research community. Branded under the family name CytoSure™, Syndrome Plus and Chromosome X exon specific arrays will debut at the European Cytogenetics Association conference in Istanbul, 7th-10th July, 2007.

CytoSure Syndrome Plus is a 105,000 feature array covering the whole genome, and includes probes designed to 85 constitutional syndromes - including Cri du Chat, di Georges and Prader-Willi – and other clinically relevant regions.

CytoSure ChrX array, a 44,000 feature array, has been developed in collaboration with Dr Philippos Patsalis, Chief Executive and Medical Director at the Cyprus Institute of Neurology and Genetics in Nicosia, Cyprus. This unique design provides comprehensive coverage of all relevant clinical areas across the X chromosome at high resolution.

CytoSure arrays will be supplied with complimentary visualisation software incorporating Copy Number Variation, gene and exon annotation to ease data interpretation and build confidence.

Dr Mike Evans, CEO of Oxford Gene Technology said: “We are very excited at OGT to be launching the CytoSure family – these are the only oligonucleotide arrays designed exclusively for the cytogenetics community and will enable cytogeneticists to achieve accurate, high resolution analysis of chromosome copy number and structural changes.”

Advertisement